Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sa La Kim"'
Autor:
Megan Agajanian, Anaamika Campeau, Malachia Hoover, Alexander Hou, Daniel Brambilla, Sa La Kim, Richard L Klemke, Jonathan A Kelber
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135748 (2015)
Transforming Growth Factor β (TGFβ) has dual functions as both a tumor suppressor and a promoter of cancer progression within the tumor microenvironment, but the molecular mechanisms by which TGFβ signaling switches between these outcomes and the
Externí odkaz:
https://doaj.org/article/632f66d557f142b78bacd7f4bbb55c74
Autor:
Joy Lin, Julie Hong, Armen Gharibi, Daniel Brambilla, Justin Molnar, Malachia Hoover, Yvess Adamian, Jonathan A. Kelber, Laurelin Wolfenden, Sa La Kim
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Scientific Reports
Scientific Reports
Pancreatic ductal adenocarcinoma (PDAC) has single-digit 5-year survival rates at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3d617a78ec12dc83af191f58599e2f
http://link.springer.com/article/10.1038/s41598-017-09946-z
http://link.springer.com/article/10.1038/s41598-017-09946-z
Autor:
Richard L. Klemke, Malachia Hoover, Daniel Brambilla, Anaamika Campeau, Jonathan A. Kelber, Sa La Kim, Megan Agajanian, Alexander Hou
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 8, p e0135748 (2015)
PLoS ONE, Vol 10, Iss 8, p e0135748 (2015)
Transforming Growth Factor β (TGFβ) has dual functions as both a tumor suppressor and a promoter of cancer progression within the tumor microenvironment, but the molecular mechanisms by which TGFβ signaling switches between these outcomes and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c89381c64ce835e62e4ca03d7255fff
https://pubmed.ncbi.nlm.nih.gov/26267863
https://pubmed.ncbi.nlm.nih.gov/26267863
Autor:
Joy Lin, Armen Gharibi, Yvess Adamian, Daniel Brambilla, Justin Molnar, Sa La Kim, Malachia Hoover, Jonathan A. Kelber, Julie Hong
Publikováno v:
Cancer Research. 77:LB-149
Pancreatic ductal adenocarcinoma (PDAC) remains one of few malignancies to have single-digit 5-year survival rates at Citation Format: Sa La Kim, Armen Gharibi, Justin Molnar, Daniel Brambilla, Yvess Adamian, Malachia Hoover, Joy Lin, Julie Hong, Jon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3612bb3a3263440eb9c45d6b6511ab17
https://doi.org/10.1158/1538-7445.am2017-lb-149
https://doi.org/10.1158/1538-7445.am2017-lb-149
Autor:
Armen Gharibi, Malachia Hoover, Sa La Kim, Jonathan A. Kelber, Joy Lin, Megan Agajanian, Laurelin Wolfenden, Yvess Adamian, Daniel Brambilla
Publikováno v:
Cancer Research. 76:4426-4426
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths in the United States with a five-year survival rate of approximately 7%. Its highly invasive characteristics, lack of biomarkers for early detection, limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5012a6d5c22b7dcd86fde10afe1cddaf
https://doi.org/10.1158/1538-7445.am2016-4426
https://doi.org/10.1158/1538-7445.am2016-4426